Ahmed Sawas
Columbia University Irving Medical Center(US)Flatiron Health (United States)(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, T-cell and Retrovirus Studies
Most-Cited Works
- → Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma(2018)248 cited
- → Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies(2021)187 cited
- → A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma(2017)133 cited
- → Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study(2019)127 cited
- → Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review(2015)114 cited
- → Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial(2017)113 cited